FDA Import Refusal SCS-3499803-0/11/1 — Sanofi
The FDA refused shipment SCS-3499803-0/11/1 from Sanofi (Canada) on Feb 12, 2019. The refused product falls under Drugs and Biologics — INSULIN (INJ) (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Feb 12, 2019
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 61PAP17 INSULIN (INJ) (ANTI-DIABETIC)
- Charges
- 75